Abstract
The in vitro susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to cefmetazole was studied by the agar dilution method. At a concentration of 16 micrograms/ml or lower, 44 isolates (96%) of M. fortuitum and 8 isolates (40%) of M. chelonei were inhibited.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Casal M. J., Rodriguez F. C. In vitro susceptibility of Mycobacterium fortuitum to non-antituberculous antibacterial agents. Ann Microbiol (Paris) 1983 Jan-Feb;134A(1):73–78. doi: 10.1016/0769-2609(83)90105-9. [DOI] [PubMed] [Google Scholar]
- Casal M. J., Rodriguez F. C. Simple, new test for rapid differentiation of the Mycobacterium fortuitum complex. J Clin Microbiol. 1981 May;13(5):989–990. doi: 10.1128/jcm.13.5.989-990.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Casal M., Rodriguez F. Etude de l'activité in vitro des bêta-lactamines et des aminosides sur Mycobacterium fortuitum. Ann Microbiol (Paris) 1981 Jul-Aug;132B(1):51–56. [PubMed] [Google Scholar]
- Casal M., Rodríguez F. In vitro susceptibility of mycobacterium fortuitum and mycobacterium chelonei to cefoxitin. Tubercle. 1982 Jun;63(2):125–127. doi: 10.1016/s0041-3879(82)80049-4. [DOI] [PubMed] [Google Scholar]
- Cynamon M. H., Palmer G. S. In vitro susceptibility of Mycobacterium fortuitum to N-formimidoyl thienamycin and several cephamycins. Antimicrob Agents Chemother. 1982 Dec;22(6):1079–1081. doi: 10.1128/aac.22.6.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cynamon M. H., Patapow A. In vitro susceptibility of Mycobacterium fortuitum to cefoxitin. Antimicrob Agents Chemother. 1981 Jan;19(1):205–207. doi: 10.1128/aac.19.1.205. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Dalovisio J. R., Pankey G. A. In vitro susceptiiblity of Mycobacterium fortuitum and Mycobacterium chelonei to amikacin. J Infect Dis. 1978 Mar;137(3):318–321. doi: 10.1093/infdis/137.3.318. [DOI] [PubMed] [Google Scholar]
- Garcia-Rodriguez J. A., Martin-Luengo F. Activity of amikacin, erythromycin and doxycyline against Mycobacterium chelonei and Mycobacterium fortuitum. Tubercle. 1978 Dec;59(4):277–280. doi: 10.1016/0041-3879(78)90005-3. [DOI] [PubMed] [Google Scholar]
- Sanders W. E., Jr, Hartwig E. C., Schneider N. J., Cacciatore R., Valdez H. Susceptibility of organisms in the Mycobacterium fortuitum complex to antituberculous and other antimicrobial agents. Antimicrob Agents Chemother. 1977 Aug;12(2):295–297. doi: 10.1128/aac.12.2.295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- VIRTANEN S. A study of nitrate reduction by mycobacteria. The use of the nitrate reduction test in the identification of mycobacteria. Acta Tuberc Scand Suppl. 1960;48:1–119. [PubMed] [Google Scholar]
- Wallace R. J., Jr, Dalovisio J. R., Pankey G. A. Disk diffusion testing of susceptibility of Mycobacterium fortuitum and Mycobacterium chelonei to antibacterial agents. Antimicrob Agents Chemother. 1979 Nov;16(5):611–614. doi: 10.1128/aac.16.5.611. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wayne L. G., Doubek J. R. Diagnostic key to mycobacteria encountered in clinical laboratories. Appl Microbiol. 1968 Jun;16(6):925–931. doi: 10.1128/am.16.6.925-931.1968. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Welch D. F., Kelly M. T. Antimicrobial susceptibility testing of Mycobacterium fortuitum complex. Antimicrob Agents Chemother. 1979 Jun;15(6):754–757. doi: 10.1128/aac.15.6.754. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wolinsky E. Nontuberculous mycobacteria and associated diseases. Am Rev Respir Dis. 1979 Jan;119(1):107–159. doi: 10.1164/arrd.1979.119.1.107. [DOI] [PubMed] [Google Scholar]